San Diego, CA 92121, U.S.A. inquiries@ansunbiopharma.com
Tel: 858-452-2631
Ansun BioPharma
  • About
    • Our Mission
    • Who We Are
    • Our Team
    • Careers
  • Science
    • Novel Approaches
    • Scientific Publications
  • Pipeline
  • Our Investors
  • News
    • Press Releases
  • Contact
Apr 02
4

Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment

By Mike Trout | Uncategorised | No Comments

https://www.prnewswire.com/news-releases/ansun-biopharma-announces-positive-results-from-investigator-initiated-trial-of-novel-covid-19-treatment-301033871.html

Read More
Jan 07
0

Ansun Biopharma to Present at Biotech Showcase 2019 in San Francisco

By admin | Uncategorised | No Comments
San Diego, CA January 7, 2019 – Ansun Biopharma, Inc. , today announced that it will present at Biotech Showcase™ 2019, to be held January 7–9, during the most important...
Read More
Oct 04
0

Ansun Biopharma Announces Key Appointments to its Executive Management Team

By admin | Uncategorised | No Comments

SAN DIEGO, Oct. 8, 2018 /PRNewswire/ — Ansun Biopharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral infections, today announced two…

Read More
Oct 02
0

Ansun Biopharma named “Fierce 15” winners in 2018

By admin | Showcase Posts | No Comments
The scoop: After years operating under the radar, Ansun Biopharma (formerly NexBio) is building momentum behind a portfolio of biologic drugs for viral infections, headlined by DAS181, a first-in-class therapy in midstage...
Read More
May 14
0

Ansun BioPharma secures $85 million in Series A Financing

By admin | Showcase Posts | No Comments
SAN DIEGO, May 14, 2018 /PRNewswire/ -- Ansun BioPharma, Inc., a leading biotechnology company focused on the development of novel broad spectrum anti-viral biologic therapeutics to combat severe viral respiratory tract infections,...
Read More

Recent Posts

  • Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment
  • Ansun Biopharma to Present at Biotech Showcase 2019 in San Francisco
  • Ansun Biopharma Announces Key Appointments to its Executive Management Team
  • Ansun Biopharma named “Fierce 15” winners in 2018
  • Ansun BioPharma secures $85 million in Series A Financing

Recent Comments

    Archives

    • April 2020
    • January 2019
    • October 2018
    • May 2018

    Categories

    • Showcase Posts
    • Uncategorised

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • Hostinger
    • 000webhost

    About Us

    About Me

    The Dentist Team

    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur lacinia nunc ac purus aliquam tincidunt. Read more..

    Dr. Med. Dentist

    Popular Articles

    • Ansun Biopharma Announces Key Appointments to its Executive Management Team 4th October 2018
    • Ansun Biopharma to Present at Biotech Showcase 2019 in San Francisco 7th January 2019
    • Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment 2nd April 2020
    • Ansun Biopharma named “Fierce 15” winners in 2018 2nd October 2018
    • Ansun BioPharma secures $85 million in Series A Financing 14th May 2018

    Recent News

    • Ansun Biopharma Announces Positive Results from Investigator-Initiated Trial of Novel COVID-19 Treatment 2nd April 2020
    • Ansun Biopharma to Present at Biotech Showcase 2019 in San Francisco 7th January 2019
    • Ansun Biopharma Announces Key Appointments to its Executive Management Team 4th October 2018

    Headquarters

    Ansun BioPharma
    3030 Callan Rd.
    San Diego, CA 92121
    U.S.A.

    Contact Us

    • Tel: 858-452-2631
    • inquiries@ansunbiopharma.com

    Search Website

    Copyright © 2021 Ansun BioPharma. All rights reserved.

    • About
      • Our Mission
      • Who We Are
      • Our Team
      • Careers
    • Science
      • Novel Approaches
      • Scientific Publications
    • Pipeline
    • Our Investors
    • News
      • Press Releases
    • Contact